These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36180755)

  • 1. Comparison of cat and human calcium oxalate monohydrate kidney stone matrix proteomes.
    Wesson JA; Zenka R; Lulich J; Eisenhauer J; Davis C
    Urolithiasis; 2022 Dec; 50(6):653-664. PubMed ID: 36180755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective protein enrichment in calcium oxalate stone matrix: a window to pathogenesis?
    Wesson JA; Kolbach-Mandel AM; Hoffmann BR; Davis C; Mandel NS
    Urolithiasis; 2019 Dec; 47(6):521-532. PubMed ID: 30993355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring mechanisms of protein influence on calcium oxalate kidney stone formation.
    Berger GK; Eisenhauer J; Vallejos A; Hoffmann B; Wesson JA
    Urolithiasis; 2021 Aug; 49(4):281-290. PubMed ID: 33587148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stone former urine proteome demonstrates a cationic shift in protein distribution compared to normal.
    Kolbach-Mandel AM; Mandel NS; Hoffmann BR; Kleinman JG; Wesson JA
    Urolithiasis; 2017 Aug; 45(4):337-346. PubMed ID: 28314883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of kidney stone formation: an analysis.
    Khan SR
    World J Urol; 1997; 15(4):236-43. PubMed ID: 9280052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein primary structure correlates with calcium oxalate stone matrix preference.
    Tian Y; Tirrell M; Davis C; Wesson JA
    PLoS One; 2021; 16(9):e0257515. PubMed ID: 34555074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.
    Khan SR
    J Urol; 2013 Mar; 189(3):803-11. PubMed ID: 23022011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of macromolecules in the formation of kidney stones.
    Rimer JD; Kolbach-Mandel AM; Ward MD; Wesson JA
    Urolithiasis; 2017 Feb; 45(1):57-74. PubMed ID: 27913854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
    Porile JL; Asplin JR; Parks JH; Nakagawa Y; Coe FL
    J Am Soc Nephrol; 1996 Apr; 7(4):602-7. PubMed ID: 8724894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the protein content of kidney stones: an explorative study.
    Steenbeke M; De Buyzere ML; Speeckaert MM; Delanghe JR
    Acta Clin Belg; 2022 Oct; 77(5):845-852. PubMed ID: 34743670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analysis of modulating activities of native human urinary Tamm-Horsfall protein on calcium oxalate crystallization, growth, aggregation, crystal-cell adhesion and invasion through extracellular matrix.
    Noonin C; Peerapen P; Yoodee S; Kapincharanon C; Kanlaya R; Thongboonkerd V
    Chem Biol Interact; 2022 Apr; 357():109879. PubMed ID: 35263610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomimetic Randall's plaque as an in vitro model system for studying the role of acidic biopolymers in idiopathic stone formation.
    Chidambaram A; Rodriguez D; Khan S; Gower L
    Urolithiasis; 2015 Jan; 43 Suppl 1(0 1):77-92. PubMed ID: 25119505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perturbations of the Gut Microbiome and Metabolome in Children with Calcium Oxalate Kidney Stone Disease.
    Denburg MR; Koepsell K; Lee JJ; Gerber J; Bittinger K; Tasian GE
    J Am Soc Nephrol; 2020 Jun; 31(6):1358-1369. PubMed ID: 32381601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
    Narula S; Tandon S; Kumar D; Varshney S; Adlakha K; Sengupta S; Singh SK; Tandon C
    Life Sci; 2020 Dec; 262():118498. PubMed ID: 32991878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of calcium oxalate urinary stone disease: species comparison of humans, dogs, and cats.
    O'Kell AL; Grant DC; Khan SR
    Urolithiasis; 2017 Aug; 45(4):329-336. PubMed ID: 28361470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second prize: Comprehensive proteomic analysis of human calcium oxalate monohydrate kidney stone matrix.
    Canales BK; Anderson L; Higgins L; Slaton J; Roberts KP; Liu N; Monga M
    J Endourol; 2008 Jun; 22(6):1161-7. PubMed ID: 18484873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.